Breaking News

Financial Report: ICON

February 19, 2013

Revenues up 24% in the quarter


4Q Revenues: $300 million (+24%)

4Q Earnings: $20.7 million (earnings were $4.1 million in 4Q11)

FY Revenues: $1.1 billion (+18%)

FY Earnings: $55.4 million  (+142%)

Comments: Operating income for the quarter was $24.4 million, up from $6.6 million in 4Q11, and 8% of revenue. For the year income from operations was $68.0 million and 6% of revenue. Backlog increased 20% for the year to $2.8 billion.
For the year restructuring and other charges were $60.4 million, or 5% of revenue.
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus